WallStreetZenWallStreetZen

NYSE: NVO
Novo Nordisk A S Stock Ownership - Who owns Novo Nordisk A S?

Open Broker Account

Insider buying vs selling

Have Novo Nordisk A S insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NVO insiders and whales buy or sell their stock.

NVO Shareholders

What type of owners hold Novo Nordisk A S stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Renaissance Technologies LLC0.68%15,308,871$1.94BInstitution
Jennison Associates LLC0.48%10,930,506$1.39BInstitution
Fisher Asset Management LLC0.41%9,332,862$1.18BInstitution
Bank Of America Corp0.32%7,321,636$929.12MInstitution
Capital International Investors0.28%6,279,859$796.91MInstitution
Fayez Sarofim Co0.23%5,218,104$662.18MInstitution
Loomis Sayles Co L P0.23%5,177,389$657.01MInstitution
Blackrock Inc0.21%4,705,266$597.10MInstitution
Folketrygdfondet0.19%4,262,659$540.93MInstitution
Wcm Investment Management LLC0.17%3,766,983$478.03MInstitution

1 of 3

NVO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVO6.10%0.00%
REGN69.51%30.49%Net BuyingNet Buying
VRTX90.97%1.46%Net SellingNet Selling
MRNA63.11%19.75%Net SellingNet Selling
BNTX15.27%0.00%

Novo Nordisk A S Stock Ownership FAQ

Who owns Novo Nordisk A S?

Novo Nordisk A S (NYSE: NVO) is owned by 6.10% institutional shareholders, 0.00% Novo Nordisk A S insiders, and 93.90% retail investors. Renaissance Technologies LLC is the largest individual Novo Nordisk A S shareholder, owning 15.31M shares representing 0.68% of the company. Renaissance Technologies LLC's Novo Nordisk A S shares are currently valued at $1.94B.

If you're new to stock investing, here's how to buy Novo Nordisk A S stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.